InvestorsHub Logo
Followers 8
Posts 1500
Boards Moderated 0
Alias Born 07/22/2013

Re: fraud fighter post# 31612

Wednesday, 08/30/2017 11:39:27 PM

Wednesday, August 30, 2017 11:39:27 PM

Post# of 108192
Fraud Fighter we're not in the same space? They are a Car-T therapy and we're a Lm Therapy! Two totally different platforms! ZIOP run up is due to them being in the same space they too are a Car-T therapy. Not all Oncology stocks are going up because of KITE deal. We're going up because small retail shorts don't want to get backasswards with there shorting of ADXS. Plain and simple . Our next conference has retail shorts nervous and the silence has been very deafing as of late. Too many good things should start to be announced in the coming months, I see green skies before the year is out! I'm hoping that they(management) have a plan in place to just release positive news every week to propel our share price back to double digits before the years out! Crazy that we're still down here after the takedown by the shorts. We were close to $10 a share before the takedown and I believe we get back to $10 in the next few months! We should have never fallen this low in the 1st place but this is the most manipulated stock I've ever been involved with. The more trials continue to show great results the harder it's going to be to manipulate the share price . I know this if I were a BP and have been involved with ADXS in any of there combo trials and see upfront and personal how well those trials are doing and seeing how well our Lm platform is doing across the board with other drugs as well I might be of sound mind to make a ridiculous offer early to steal the platform before paying a $12 billion buyout for ADXS in the next couple years! Plenty of smart people watching ADXS right now! Trust me in the clinical trial circles certain individuals hold a lot of clout on there opinions of what they see working and what's not working. I believe ADXS is creating a BUZZ about the Lm platform and its delivery system. Amgen seemed to bow out on KITE deal why? Was the treatment going to be too expensive and not worth the time and energy to peddle a $450,000 one time treatment to a small group of patients ? Whatever the reasons they passed on KITE , my feeling is Amgen is in desperate need of new Oncology treatments thus NEO with ADXS. Our treatments are effective and safe with very little expense to manufacture. Making profit margins in the stratosphere yet making cancer treatments very affordable for all patients not just the rich ones! Our Lm platform not only could be the new frontier of the way cancer is fought in the near future it could be a life saving treatment to anyone in the world! Think about how expensive most of these cancer treatments are...Our platform could change how 3rd world countries fight cancer now! I'm sure no body except the very wealthy get a chance at battling cancer , we could be the "GOOD GUYS" that offer special prices for undeveloped countries and gain nation wide publicity for helping everyone that other wise wouldn't be able to afford treatment! Our market share in the Immunotherapy world would be off the charts if we can achieve higher survival rates than our GOG trial!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News